Event Panel Schedule


TBA
Re­cap of 2020 & The dif­fer­ent IPO mod­els – What have we learned? What worked? What is here to stay? What do we miss the most?
Webcast
6c8773435f893c60018d32a5aa841a36_c43900f83a9b9f91a90471009e489938_120_120
Oppenheimer & Co. Inc.
Stefan Loren, Ph.D., Managing Director / Oppenheimer & Co. Inc.
Loren is a managing director at Oppenheimer & Co.. Prior to joining Oppenheimer Loren was managing partner at Leap Day Capital (2014-2017) and board director for GenVec (2013-2017). Loren graduated with a PhD. in Organic/Pharmaceutical…

A4fadbc30dd51f3c45ce345b0c45d7d9_60e02904d329da7ce16b05fd9ed1f9e8_120_120
Oppenheimer & Co. Inc.
Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking / Oppenheimer & Co. Inc.
Mr. Michael Margolis serves as Co-Head of Healthcare Investment Banking at Oppenheimer & Company. He served as a Managing Director, Healthcare Investment Banking at Roth Capital Partners. He was most recently a Managing Director of Healthcare…

71c12c3bf0e1dd51dc7bb06172906e50_ad8d8087d2ce5522e4f90768921fcbfc_120_120
Alpha Healthcare Acquisition
Rajiv Shukla, Chairman & CEO / Alpha Healthcare Acquisition
Alpha Healthcare Acquisition Corp is led by Chairman and CEO, Rajiv Shukla. Rajiv is a long-time healthcare investor and 3-time public company CEO. His previous SPAC acquired DermTech, a disruptive non-invasive cancer diagnostic company. DMTK stock…

1298480e85ef6e84355b23077fd3a29a_cfd06a48ede181611fa7477b96186215_120_120
Larimar Therapeutics
Michael Celano, CFO / Larimar Therapeutics
Michael Celano joined Larimar Therapeutics in June 2020, as Chief Financial Officer (CFO). He brings over 30 years’ experience as a life science business leader with a broad skill set including capital raising, creative financing structures, investor…

Ed4e194f08b0f4dc8ae61cc9eeed91cd_a9a6a78ed2742e0617991b70f9d1db74_120_120
Solebury Trout
Jennifer Porcelli, Managing Director / Solebury Trout
Jen Porcelli is a Managing Director in the New York office. Jen works with a broad spectrum of privately-held and publicly-traded life sciences companies throughout various stages of the funding lifecycle; she provides management teams with…

98b8e47210bfec3e958958dbf9c5ac74_c0441e5e62840d7c8ab8d794876a996b_120_120
White & Case LLP
Joel Rubinstein, Partner / White & Case LLP
Joel Rubinstein is a partner at White & Case, and a member of the Firm’s Capital Markets Practice. Joel has broad experience in corporate and securities matters, representing clients in public offerings and private placements of securities…

Ede199a05e3b941c16158899c348ab6e_e79c338f92d121a53b1f155a41684c90_120_120
White & Case LLP
Stuart Bressman, Partner / White & Case LLP
Stuart advises investment banks and issuers on public and private securities offerings by US and non-US companies. Clients also seek him out for his market-leading experience in alternative financing techniques, such as confidentially marketed public…
Export to Excel